Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Tubach

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
BJOG : an International Journal of Obstetrics and Gynaecology|November 20, 2020
Authors' reply re: Caesarean section in the second delivery to prevent anal incontinence after asymptomatic obstetrical anal sphincter injury: the EPIC multicentre randomised trialLaurent Abramowitz, Laurent Mandelbrot, Florence Tubach, et al.
The American Journal of the Medical Sciences|November 22, 2007
Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature reviewLaure Gossec, Florence Tubach, Maxime Dougados, et al.
Journal of Epidemiology and Population Health|March 20, 2025
Risque de maladies inflammatoires à médiation immunitaire associé aux anti-TNF et à l'ustékinumab chez les patients atteints de maladie de Crohn : étude des données du système national des données de santé (SNDS)Julien Kirchgesner, Caroline Giboin, Raphaelle Curmin, et al.
JAMA|August 28, 2003
Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritisIsabelle Boutron, Florence Tubach, Bruno Giraudeau, et al.
Journal of Clinical Epidemiology|July 13, 2004
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trialsIsabelle Boutron, Florence Tubach, Bruno Giraudeau, et al.
The Journal of Rheumatology|October 6, 2005
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issuesFlorence Tubach, George A Wells, Philippe Ravaud, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 25, 2019
Trajectories of Adherence to Low-Dose Aspirin Treatment Among the French PopulationAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2017
Evaluation of algorithms to identify incident cancer cases by using French health administrative databasesAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
Joint Bone Spine|November 29, 2005
The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapyFlorence Tubach, Dominique Salmon-Céron, Philippe Ravaud, et al.
Statistics in Medicine|November 19, 2016
Estimation of conditional and marginal odds ratios using the prognostic scoreDavid Hajage, Yann De Rycke, Guillaume Chauvet, et al.
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
BJOG : an International Journal of Obstetrics and Gynaecology|November 20, 2020
Authors' reply re: Caesarean section in the second delivery to prevent anal incontinence after asymptomatic obstetrical anal sphincter injury: the EPIC multicentre randomised trialLaurent Abramowitz, Laurent Mandelbrot, Florence Tubach, et al.
The American Journal of the Medical Sciences|November 22, 2007
Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature reviewLaure Gossec, Florence Tubach, Maxime Dougados, et al.
Journal of Epidemiology and Population Health|March 20, 2025
Risque de maladies inflammatoires à médiation immunitaire associé aux anti-TNF et à l'ustékinumab chez les patients atteints de maladie de Crohn : étude des données du système national des données de santé (SNDS)Julien Kirchgesner, Caroline Giboin, Raphaelle Curmin, et al.
JAMA|August 28, 2003
Methodological differences in clinical trials evaluating nonpharmacological and pharmacological treatments of hip and knee osteoarthritisIsabelle Boutron, Florence Tubach, Bruno Giraudeau, et al.
Journal of Clinical Epidemiology|July 13, 2004
Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trialsIsabelle Boutron, Florence Tubach, Bruno Giraudeau, et al.
The Journal of Rheumatology|October 6, 2005
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issuesFlorence Tubach, George A Wells, Philippe Ravaud, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|July 25, 2019
Trajectories of Adherence to Low-Dose Aspirin Treatment Among the French PopulationAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2017
Evaluation of algorithms to identify incident cancer cases by using French health administrative databasesAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
Joint Bone Spine|November 29, 2005
The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapyFlorence Tubach, Dominique Salmon-Céron, Philippe Ravaud, et al.
Statistics in Medicine|November 19, 2016
Estimation of conditional and marginal odds ratios using the prognostic scoreDavid Hajage, Yann De Rycke, Guillaume Chauvet, et al.
Pageof 27